ClinicalTrials.govpublic full text
A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
metastatic gastric cancer, metastatic breast cancer, endometrial cancer metastatic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 831884
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.